A proposal to further reduce Medicaid drug reimbursement that was included in President Obama’s fiscal year 2014 budget plan is “premature” and federal Medicaid officials should focus on modifying and completing already proposed regulations to set future federal upper limits for reimbursement of most generic drugs, the National Association of Chain Drug Stores and the National Community Pharmacists Association said.
The government of Canada's Alberta province will pay pharmacists $1 for each prescription filled as part of a one-year transition program for which it will spend $24 million, according to published reports.
Research has indicated that about half of antibiotic prescriptions are unnecessary, raising concerns about the growth of bacteria resistant to them, but a new study by researchers at the Centers for Disease Control and Prevention also finds that prescriptions are highest in several states in the South and Midwest.
Those older than 40 years may be making a negative impact on the future of the U.S. economy with the way they eat, live and keep track of their health, according to a white paper released Wednesday by the MetLife Mature Market Institute and co-authored by the Center for Healthy Aging.
A desire to save money is driving younger and older adults to request cheaper drugs from their doctors, but it's also driving younger adults not to take their drugs as prescribed, according to a new study.
A growing number of patients on Medicaid are filling their prescriptions through Managed Medicaid plans instead of the fee-for-service model as states switch them over in an effort to improve patient care and cut healthcare costs, but the effects remain unclear, according to a new study.
More than one-tenth of school-age children and nearly one-fifth of high school boys in the United States have received a diagnosis for attention deficit hyperactivity disorder, according to published reports.
A coalition of drug and pharmacy organizations formed to address patients' medication needs during disasters is changing the name and Web address of its reporting system to make it easier to remember, the organization said Tuesday.
Just a week after the Supreme Court heard the Federal Trade Commission's lawsuit over its deal with AbbVie to sell a generic version of a testosterone-replacement therapy, Actavis is challenging the patent on another strength of the drug.